CRBP

Corbus Pharmaceuticals Holdings, Inc.

8.63

USD

CRBP Earnings Reports

Positive Surprise Ratio

CRBP beat 21 of 40 last estimates.

53%

Next Report

Date of Next Report

Mar 09, 2026

Estimate for Q4 25 (Revenue/ EPS)

$1.70M

-$1.66

Implied change from Q3 25 (Revenue/ EPS)

-12.63%

Implied change from Q4 24 (Revenue/ EPS)

+112.82%

Corbus Pharmaceuticals Holdings, Inc. earnings per share and revenue

On Nov 12, 2025, CRBP reported earnings of -1.90 USD per share (EPS) for Q3 25, missing the estimate of -1.74 USD, resulting in a -9.11% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.39% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 12 analysts forecast an EPS of -1.66 USD, with revenue projected to reach 1.70 million USD, implying an decrease of -12.63% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Corbus Pharmaceuticals Holdings, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Corbus Pharmaceuticals Holdings, Inc. reported EPS of -$1.90, missing estimates by -9.11%, and revenue of $0.00, 0% as expectations.

How did the market react to Corbus Pharmaceuticals Holdings, Inc.'s Q3 2025 earnings?

The stock price moved up 7.39%, changed from $10.42 before the earnings release to $11.19 the day after.

When is Corbus Pharmaceuticals Holdings, Inc. expected to report next?

The next earning report is scheduled for Mar 09, 2026.

What are the forecasts for Corbus Pharmaceuticals Holdings, Inc.'s next earnings report?

Based on 12 analysts, Corbus Pharmaceuticals Holdings, Inc. is expected to report EPS of -$1.66 and revenue of $1.70M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.